Codupha Central Pharmaceutical JSC (CDP.VN) Stock Price
Codupha Central Pharmaceutical JSC Price
Revenue at Codupha Central Pharmaceutical JSC has contracted by 1.9% per year over the past 7 years to 3.21 T VND. Earnings per share have declined at 9.6% per year over the last 7 years. For Codupha Central Pharmaceutical JSC, the net margin of 0.4% is broadly stable versus 0.4% a few years ago. At today's price the dividend yield works out to roughly 4.81%. The payout ratio is around 65% of earnings.
Codupha Central Pharmaceutical JSC stock price
Codupha Central Pharmaceutical JSC business model & stock analysis
Frequently asked questions about Codupha Central Pharmaceutical JSC
Converted at the current exchange rate, the Codupha Central Pharmaceutical JSC share trades at 0.36 EUR (10,400.00 VND).
The revenue cannot currently be calculated for Codupha Central Pharmaceutical JSC.
The profit cannot currently be calculated for Codupha Central Pharmaceutical JSC.
The P/E ratio cannot be calculated for Codupha Central Pharmaceutical JSC at the moment.
The P/S cannot be calculated for Codupha Central Pharmaceutical JSC currently.
The Eulerpool Quality Score for Codupha Central Pharmaceutical JSC is 3/10.
The ISIN of Codupha Central Pharmaceutical JSC is VN000000CDP2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Codupha Central Pharmaceutical JSC is CDP.VN. The ticker symbol is used to trade Codupha Central Pharmaceutical JSC shares on the stock exchange.
Codupha Central Pharmaceutical JSC stock
Codupha Central Pharmaceutical JSC Peer Group
Codupha Central Pharmaceutical JSC FIGI
All fundamentals and in-depth analysis of Codupha Central Pharmaceutical JSC
Our stock analysis for Codupha Central Pharmaceutical JSC stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Codupha Central Pharmaceutical JSC. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.